Cardiology, Rigshospitalet, Kobenhavn, Denmark
Cardiology, Rigshospitalet, Kobenhavn, Denmark.
Open Heart. 2021 Apr;8(1). doi: 10.1136/openhrt-2020-001564.
The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.
经导管二尖瓣修复(TMVr)治疗二尖瓣反流(MR)领域正在迅速发展。除了已确立的经导管二尖瓣瓣环成形术和二尖瓣瓣叶修复术,针对二尖瓣瓣环和二尖瓣腱索的治疗策略也有了更多证据。个体化治疗方法、仔细的患者选择和经验丰富的介入团队对于优化手术和临床结果至关重要。随着即将出现更多的临床试验数据,需要心脏团队达成共识,以解决这些复杂性问题,并确定最适合严重 MR 患者的单一或联合 TMVr 治疗方法。